CHANGE OF RECEIPT DATE FOR EARLY CLINICAL TRIALS OF NEW ANTI-CANCER AGENTS WITH PHASE I EMPHASIS Release Date: January 14, 2002 NOTICE: NOT-CA-02-015 National Cancer Institute The National Cancer Institute (NCI) wishes to give notice of a change of receipt date for applications submitted in response to RFA CA-02-011, EARLY CLINICAL TRIALS OF NEW ANTI-CANCER AGENTS WITH PHASE I EMPHASIS. This RFA appeared in the November 19, 2001 issue of the NIH Guide for Grants and Contracts. The previous receipt date of March 21, 2002 has been changed to March 28, 2002. All other aspects of this RFA remain unchanged. This RFA can be accessed at the following URL: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-02-011.html. INQUIRIES Inquiries regarding this notice may be directed to: Dr. Louise B. Grochow Chief, Investigational Drug Branch Cancer Therapy Evaluation Program Division of Cancer Treatment and Diagnosis National Cancer Institute Executive Plaza North, Room 7131 6130 Executive Blvd MSC 7426 Bethesda, MD 20892-7432 Telephone: (301) 496-1196 Fax: (301) 402-0428 E-mail: grochowl@ctep.nci.nih.gov
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |